Adler M
Adv Ther. 1999 Mar-Apr;16(2):103-11.
The efficacy and safety of a fixed-combination homeopathic medication (Sinusitis PMD) consisting of Lobaria pulmonaria, Luffa operculata, and potassium dichromate were investigated in an open-label practice-based study of 119 male and female patients, 12 to 57 years of age, with clinical signs of acute sinusitis not previously treated. At the first visit, after a mean of 4.1 days of treatment, secretolysis had increased significantly and typical sinusitis symptoms, such as headache, pressure pain at nerve exit points, and irritating cough, were reduced. Ninety-nine patients received only the test medication. Twenty patients were able to discontinue concomitant medication at the first visit. Only one patient needed an antibiotic. The average treatment duration was 2 weeks. At the end of treatment, 81.5% of patients described themselves as symptom free or significantly improved. Adverse drug effects were not reported.
在一项基于实践的开放标签研究中，对119名年龄在12至57岁、有急性鼻窦炎临床症状且此前未接受过治疗的男性和女性患者，研究了一种由肺衣、丝瓜和重铬酸钾组成的固定复方顺势疗法药物（鼻窦炎PMD）的疗效和安全性。在首次就诊时，平均治疗4.1天后，分泌物溶解显著增加，典型的鼻窦炎症状，如头痛、神经出口点压痛和刺激性咳嗽有所减轻。99名患者仅接受了试验药物治疗。20名患者在首次就诊时能够停用联合用药。只有1名患者需要使用抗生素。平均治疗持续时间为2周。治疗结束时，81.5%的患者表示自己无症状或有显著改善。未报告药物不良反应。
